Are the anatomical sites for vaccine administration selected judiciously?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Immunopharmacology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.intimp.2013.12.023PMID 24406427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Immunogenicity of a Tricomponent Mannan Tetanus Toxoid Conjugate Vaccine Targeted to Dendritic Cells via Dectin-1 by Incorporating β-Glucan

  2013cited by this paper
• Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

  2013cited by this paper
• A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo

  2013cited by this paper
• Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection

  2012cited by this paper
• Characterization of MHC-II antigen presentation by B cells and monocytes from older individuals.

  2012cited by this paper
• Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.

  2012cited by this paper
• Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization

  2012cited by this paper
• Lymphatic Transport and Catabolism of Therapeutic Proteins after Subcutaneous Administration to Rats and Dogs

  2012cited by this paper
• The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.

  2012cited by this paper
• Characterization of resident and migratory dendritic cells in human lymph nodes

  2012cited by this paper
• Novel vaccine development strategies for inducing mucosal immunity

  2012cited by this paper
• Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses

  2012cited by this paper
• Rational Design of Pathogen-Mimicking Amphiphilic Materials as Nanoadjuvants

  2011cited by this paper
• Surface engineered nanoparticles for oral immunization.

  2011cited by this paper
• Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials.

  2011cited by this paper
• Lung CD103+ Dendritic Cells Efficiently Transport Influenza Virus to the Lymph Node and Load Viral Antigen onto MHC Class I for Presentation to CD8 T Cells

  2011cited by this paper
• Effects of Different Adjuvants in the Context of Intramuscular and Intranasal Routes on Humoral and Cellular Immune Responses Induced by Detergent-Split A/H3N2 Influenza Vaccines in Mice

  2011cited by this paper
• Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine

  2011cited by this paper
• Implication of gut immunology in the design of oral vaccines.

  2010cited by this paper
• CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells

  2010cited by this paper
• Mannosylated liposomes for targeted vaccines delivery.

  2010cited by this paper
• PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.

  2010cited by this paper
• A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation

  2010cited by this paper
• Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

  2010cited by this paper
• Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial

  2010cited by this paper
• Bronchus-associated lymphoid tissue: an entry site for antigens for successful mucosal vaccinations?

  2010cited by this paper
• Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.

  2010cited by this paper
• Evaluation of Mucoadhesive PLGA Microparticles for Nasal Immunization

  2010cited by this paper
• M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum.

  2010cited by this paper
• Eye Mucosa: An Efficient Vaccine Delivery Route for Inducing Protective Immunity

  2010cited by this paper
• In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis

  2009cited by this paper
• Inflammatory signals in dendritic cell activation and the induction of adaptive immunity

  2009cited by this paper
• Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239

  2009cited by this paper
• Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.

  2008cited by this paper
• Detection and characterization of engineered nanoparticles in food and the environment

  2008cited by this paper
• Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).

  2008cited by this paper
• Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch.

  2008cited by this paper
• Dendritic cell subsets in lymph nodes are characterized by the specific draining area and influence the phenotype and fate of primed T cells

  2008cited by this paper
• Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice.

  2007cited by this paper
• The development of stable influenza vaccine powder formulations for new needle-free dosage forms

  2007cited by this paper
• Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.

  2007cited by this paper
• Mannosylated Niosomes as Adjuvant-Carrier System for Oral Mucosal Immunization

  2006cited by this paper
• Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue

  2006cited by this paper
• Differential Pattern Recognition Receptor Expression but Stereotyped Responsiveness in Rat Spleen Dendritic Cell Subsets1

  2006cited by this paper
• Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens.

  2005cited by this paper
• Sphingosine-1-Phosphate Mediates Migration of Mature Dendritic Cells1

  2005cited by this paper
• Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes.

  2005cited by this paper
• Let's go mucosal: communication on slippery ground.

  2004cited by this paper
• Transcriptional regulation of the mucosal IgA system.

  2004cited by this paper
• Role of secretory antibodies in the defence against infections.

  2003cited by this paper
• Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus.

  2003cited by this paper
• Intestinal IgA synthesis: regulation of front-line body defences

  2003cited by this paper
• Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

  2003cited by this paper
• Antigen targeted to secondary lymphoid organs via vascular cell adhesion molecule (VCAM) enhances an immune response.

  2003cited by this paper
• Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node

  2002cited by this paper
• Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.

  2002cited by this paper
• Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.

  2001cited by this paper
• Lymphatic transport of proteins after s.c. injection: implications of animal model selection.

  2001cited by this paper
• M cell-targeted DNA vaccination

  2001cited by this paper
• T-cell function and migration. Two sides of the same coin.

  2000cited by this paper
• Effects of the Nature of Adjuvant and Site of Parenteral Immunization on the Serum and Mucosal Immune Responses Induced by a Nasal Boost with a Vaccine Alone

  1998cited by this paper
• Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization

  1997cited by this paper
• Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways.

  1994cited by this paper
• The role of nasopharyngeal lymphoid tissue.

  1992cited by this paper
• The Waldeyer ring equivalent in the rat. A model for analysis of oronasopharyngeal immune responses.

  1991cited by this paper
• Dendritic cells in the respiratory tract.

  1990cited by this paper
• Lymphoid and non-lymphoid cells in nasal-associated lymphoid tissue (NALT) in the rat

  1990cited by this paper
• Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination.

  1989cited by this paper
• Immune response to hepatitis b vaccine given at different injection sites and by different routes a controlled randomized study

  1988cited by this paper
• The spleen in lymphocyte migration.

  1988cited by this paper
• The route of re-circulation of lymphocytes in the rat

  1964cited by this paper
• Portals of entry for bacterial infection in calves and piglets with particular reference to the tonsil.

  1963cited by this paper
• The output of lymphocytes from the thoracic duct of unanaesthetized mice.

  1962cited by this paper

• Composition, stabilization and delivery of virus-based vaccines: considerations to break free of the cold chain.

  2025cites this paper
• Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy

  2024cites this paper
• Intra‐lymph node crosslinking of antigen‐bearing polymers enhances humoral immunity and dendritic cell activation

  2024cites this paper
• Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection.

  2023cites this paper
• Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria

  2022cites this paper
• Effectiveness and safety of tetanus vaccine administration by intramuscular vs. subcutaneous route in anticoagulated patients: Randomized clinical trial in primary care

  2022cites this paper
• Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model

  2022cites this paper
• Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model.

  2020cites this paper
• Prophylactic DC Vaccination Controls Pancreatic Cancer Growth in a Mouse Model

  2020cites this paper
• Introduction to dendritic cell vaccines immunotherapy for glioblastoma multiforme : A novel approach

  2019cites this paper
• Estrategias de protección inmunitaria. Una visión desde la homeopatía. Fundamentada en nanopartÍculas

  2019influential citation
• 19F-MRI to Monitor Therapeutic Cell Migration and Distribution

  2018cites this paper
• Mouse dendritic cell migration in abdominal lymph nodes by intraperitoneal administration.

  2018cites this paper
• CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice

  2017cites this paper
• Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.

  2017influential citation
• ADME Processes in Vaccines and PK/PD Approaches for Vaccination Optimization

  2015cites this paper
• Effect of vaccine administration modality on immunogenicity and efficacy

  2015cites this paper
• Severe Upper Extremity Dysfunction After 4CMenB Vaccination in a Young Infant.

  2015cites this paper
• Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

  2015cites this paper
• Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity

  2015cites this paper
• Immunogenicity of infectious pathogens and vaccine antigens

  2015cites this paper